Wutah dodolan YoY sajrone 12 wulan kepungkur: intensitytherapeutics.com (INTS)

Logo perusahaan publik intensitytherapeutics.com (INTS)

Intensity Therapeutics minimizes oncological risks by developing injection methods directly into neoplasms. This chart of trailing 12-month year-over-year revenue growth demonstrates the impact of this strategy, where the metric is recorded at 0.00. Synergy with pharma behemoths and the acquisition of patents support development, although costs for final tests create financial pressure and a dependence on external funding.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Intensity Tx (INTS): kanggo periode 23.11.2025 - 17.11.2026

Intensity Therapeutics (INTS) - rincian metrik lan laporan keuangan

Ringkesan analitik perusahaan:Intensity Therapeutics
Sampel barang Intensity Tx

Intensity Therapeutics focuses on developing the high-tech DATH platform for targeted oncology therapy. This indicator captures the percentage change in revenue over the last 12 months relative to the same preceding period. The metric allows for an assessment of the commercial scalability of R&D projects and the pace of innovation monetization. A stable trend confirms market demand for the company's developments. By analyzing the relative sales growth over a 12-month period compared to the previous year, an investor determines the stage of business development.

Pesaing Intensity Therapeutics (INTS)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|lyell.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Innate Pharma S.A|Pyxis (PYXS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Compugen Ltd - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|IOBT (iobiotech.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) Sutro Biopharma Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur MiNK Therapeutics (INKT)|HOWL: Wutah dodolan taun lumaku|Immix Biopharma - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ALX Oncology (ALXO) - Wutah pendapatan taun lumaku|CUE: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku PDSB|sonnetbio.com (SONN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|MAIA Biotechnology Inc (MAIA) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur liminatuspharma.com|Wutah dodolan YoY sajrone rolas wulan kepungkur LVTX|Wutah pendapatan YoY sajrone 12 wulan kepungkur NXTC (NextCure, Inc.)|LPTX: Wutah dodolan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur